| . | Patients . |
|---|---|
| Number of patients (n) | 43 |
| CoreValve | 3 |
| Size: 26/29/31 mm | 1/2/- |
| Edwards SAPIEN valve | 40 |
| Size: 23/26/29 mm | 6/18/16 |
| Intra-aortic balloon pump | |
| Preoperative | 2 (4.7%) |
| Postoperative | 7 (16%) |
| Pacemaker implantation | |
| DDD/VVI | 1/2 (7%) |
| Reason for CPB | |
| Cardiogenic shock | 23 (53%) |
| Impaired LV function | 16 (37%) |
| Impaired RV function | 2 (5%) |
| Pulmonary hypertension and enlarged RV | 2 (5%) |
| CPB bypass time (min) | |
| All patients | 20 (5–297) |
| Patients with cardiogenic shock | 41 (11–297) |
| Patients with impaired LV or RV function, or pulmonary hypertension with enlarged RV | 14 (6–40) |
| . | Patients . |
|---|---|
| Number of patients (n) | 43 |
| CoreValve | 3 |
| Size: 26/29/31 mm | 1/2/- |
| Edwards SAPIEN valve | 40 |
| Size: 23/26/29 mm | 6/18/16 |
| Intra-aortic balloon pump | |
| Preoperative | 2 (4.7%) |
| Postoperative | 7 (16%) |
| Pacemaker implantation | |
| DDD/VVI | 1/2 (7%) |
| Reason for CPB | |
| Cardiogenic shock | 23 (53%) |
| Impaired LV function | 16 (37%) |
| Impaired RV function | 2 (5%) |
| Pulmonary hypertension and enlarged RV | 2 (5%) |
| CPB bypass time (min) | |
| All patients | 20 (5–297) |
| Patients with cardiogenic shock | 41 (11–297) |
| Patients with impaired LV or RV function, or pulmonary hypertension with enlarged RV | 14 (6–40) |
Data are presented as [n]/% or mean ± SD, range or median, range.
CPB: cardiopulmonary bypass; DDD: dual chamber pacemaker; LV: left ventricular; RV: right ventricular; VVI: ventricular pacemaker.
| . | Patients . |
|---|---|
| Number of patients (n) | 43 |
| CoreValve | 3 |
| Size: 26/29/31 mm | 1/2/- |
| Edwards SAPIEN valve | 40 |
| Size: 23/26/29 mm | 6/18/16 |
| Intra-aortic balloon pump | |
| Preoperative | 2 (4.7%) |
| Postoperative | 7 (16%) |
| Pacemaker implantation | |
| DDD/VVI | 1/2 (7%) |
| Reason for CPB | |
| Cardiogenic shock | 23 (53%) |
| Impaired LV function | 16 (37%) |
| Impaired RV function | 2 (5%) |
| Pulmonary hypertension and enlarged RV | 2 (5%) |
| CPB bypass time (min) | |
| All patients | 20 (5–297) |
| Patients with cardiogenic shock | 41 (11–297) |
| Patients with impaired LV or RV function, or pulmonary hypertension with enlarged RV | 14 (6–40) |
| . | Patients . |
|---|---|
| Number of patients (n) | 43 |
| CoreValve | 3 |
| Size: 26/29/31 mm | 1/2/- |
| Edwards SAPIEN valve | 40 |
| Size: 23/26/29 mm | 6/18/16 |
| Intra-aortic balloon pump | |
| Preoperative | 2 (4.7%) |
| Postoperative | 7 (16%) |
| Pacemaker implantation | |
| DDD/VVI | 1/2 (7%) |
| Reason for CPB | |
| Cardiogenic shock | 23 (53%) |
| Impaired LV function | 16 (37%) |
| Impaired RV function | 2 (5%) |
| Pulmonary hypertension and enlarged RV | 2 (5%) |
| CPB bypass time (min) | |
| All patients | 20 (5–297) |
| Patients with cardiogenic shock | 41 (11–297) |
| Patients with impaired LV or RV function, or pulmonary hypertension with enlarged RV | 14 (6–40) |
Data are presented as [n]/% or mean ± SD, range or median, range.
CPB: cardiopulmonary bypass; DDD: dual chamber pacemaker; LV: left ventricular; RV: right ventricular; VVI: ventricular pacemaker.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
